More recently, Tα1 was found to reverse M2 polarization of efferocytosis-activated macrophages in cancer patients (113) and, in the context of immune check-point inhibitor therapy, to enhance anti-tumor activity (114) via the promotion of dendritic cell activity (115). Here, TAAR1 is linked to neoplasm.